<DOC>
	<DOCNO>NCT01496521</DOCNO>
	<brief_summary>Evidence laboratory study suggest aspirin tea polyphenols may antineoplastic effect esophageal squamous cell carcinoma ( ESCC ) . To assess safety efficacy aspirin tea polyphenols prevent ESCC , investigator design double-blind , randomize control clinical trial . Research project plan recruit 10,000 participant age 40-60 year Fengfeng city , Hebei province , China , know high incidence region ESCC . All participant receive endoscopic examination . Lugol 's chromoendoscopy use identify esophageal unstained lesion ( USLs ) . The location size USL record follow collect biopsy sample USL . Participants USL randomly assign receive 100 mg/d aspirin ( n=200 ) , 100 mg/d tea polyphenols ( n=200 ) , placebo ( n=200 ) six month . Follow-up consist 2 endoscopic surveillance cycle ( first interval six month second 3 5 year later ) . The primary outcome measure occurrence high grade dysplasia invasive ESCC . Secondary outcome mortality participant adverse event .</brief_summary>
	<brief_title>Chemoprevention Esophageal Squamous Cell Carcinoma ( ESCC ) With Aspirin Tea Polyphenols</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>1. age 40 60 year ; 2 . Lugol 's chromoendoscopy show least one USL 1 cm large contain mild moderate dysplasia chronic inflammation ; 3. subject neither pregnant intending become pregnant study . 1. current nonsteroidal antiinflammatory drug ( NSAID ) therapy ; 2. major intercurrent illness ; 3. pregnancy ; 4. invasive carcinoma ; 5. condition could worsen aspirin tea polyphenols .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>polyphenols</keyword>
	<keyword>Chemoprevention</keyword>
</DOC>